Literature DB >> 26507245

Mechanisms of gene targeting in higher eukaryotes.

Akinori Tokunaga1,2, Hirofumi Anai3, Katsuhiro Hanada4.   

Abstract

Targeted genome modifications using techniques that alter the genomic information of interest have contributed to multiple studies in both basic and applied biology. Traditionally, in gene targeting, the target-site integration of a targeting vector by homologous recombination is used. However, this strategy has several technical problems. The first problem is the extremely low frequency of gene targeting, which makes obtaining recombinant clones an extremely labor intensive task. The second issue is the limited number of biomaterials to which gene targeting can be applied. Traditional gene targeting hardly occurs in most of the human adherent cell lines. However, a new approach using designer nucleases that can introduce site-specific double-strand breaks in genomic DNAs has increased the efficiency of gene targeting. This new method has also expanded the number of biomaterials to which gene targeting could be applied. Here, we summarize various strategies for target gene modification, including a comparison of traditional gene targeting with designer nucleases.

Entities:  

Keywords:  Designer nucleases; Double-stranded DNA breaks; Homologous recombination

Mesh:

Substances:

Year:  2015        PMID: 26507245     DOI: 10.1007/s00018-015-2073-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  60 in total

1.  Human Mus81-associated endonuclease cleaves Holliday junctions in vitro.

Authors:  X B Chen; R Melchionna; C M Denis; Pierre-Henri L Gaillard; A Blasina; I Van de Weyer; M N Boddy; P Russell; J Vialard; C H McGowan
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

2.  TAL effector RVD specificities and efficiencies.

Authors:  Jana Streubel; Christina Blücher; Angelika Landgraf; Jens Boch
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

Review 3.  Therapeutic gene targeting.

Authors:  R J Yáñez; A C Porter
Journal:  Gene Ther       Date:  1998-02       Impact factor: 5.250

Review 4.  Cas9-based genome editing in zebrafish.

Authors:  Andrew P W Gonzales; Jing-Ruey Joanna Yeh
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

Review 5.  Genome editing at the crossroads of delivery, specificity, and fidelity.

Authors:  Ignazio Maggio; Manuel A F V Gonçalves
Journal:  Trends Biotechnol       Date:  2015-03-26       Impact factor: 19.536

6.  Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro.

Authors:  P Baumann; F E Benson; S C West
Journal:  Cell       Date:  1996-11-15       Impact factor: 41.582

7.  Ionizing radiation-induced foci formation of mammalian Rad51 and Rad54 depends on the Rad51 paralogs, but not on Rad52.

Authors:  Lieneke R van Veelen; Jeroen Essers; Mandy W M M van de Rakt; Hanny Odijk; Albert Pastink; Małgorzata Z Zdzienicka; Coen C Paulusma; Roland Kanaar
Journal:  Mutat Res       Date:  2005-04-09       Impact factor: 2.433

8.  Conservative homologous recombination preferentially repairs DNA double-strand breaks in the S phase of the cell cycle in human cells.

Authors:  Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2004-07-13       Impact factor: 16.971

9.  Efficient targeting of a SCID gene by an engineered single-chain homing endonuclease.

Authors:  Sylvestre Grizot; Julianne Smith; Fayza Daboussi; Jesús Prieto; Pilar Redondo; Nekane Merino; Maider Villate; Séverine Thomas; Laetitia Lemaire; Guillermo Montoya; Francisco J Blanco; Frédéric Pâques; Philippe Duchateau
Journal:  Nucleic Acids Res       Date:  2009-07-07       Impact factor: 16.971

10.  Single-step generation of rabbits carrying a targeted allele of the tyrosinase gene using CRISPR/Cas9.

Authors:  Arata Honda; Michiko Hirose; Tadashi Sankai; Lubna Yasmin; Kazuaki Yuzawa; Kimiko Honsho; Haruna Izu; Atsushi Iguchi; Masahito Ikawa; Atsuo Ogura
Journal:  Exp Anim       Date:  2014-09-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.